|
LOC595101 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.038000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.189000E-01 |
| Normal-vs-Stage2 |
8.362800E-01 |
| Normal-vs-Stage3 |
9.665200E-01 |
| Normal-vs-Stage4 |
3.285000E-01 |
| Stage1-vs-Stage2 |
3.592000E-01 |
| Stage1-vs-Stage3 |
4.744800E-01 |
| Stage1-vs-Stage4 |
5.978200E-01 |
| Stage2-vs-Stage3 |
8.230400E-01 |
| Stage2-vs-Stage4 |
3.447400E-01 |
| Stage3-vs-Stage4 |
3.991200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.446400E-01 |
| Normal-vs-AfricanAmerican |
5.618000E-01 |
| Normal-vs-Asian |
8.399800E-01 |
| Caucasian-vs-AfricanAmerican |
9.140100E-02 |
| Caucasian-vs-Asian |
9.380600E-01 |
| AfricanAmerican-vs-Asian |
6.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.326400E-01 |
| Normal-vs-Female |
5.976400E-01 |
| Male-vs-Female |
7.699600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.396000E-01 |
| Normal-vs-Extreme_Weight |
2.183800E-01 |
| Normal-vs-Obese |
6.011000E-01 |
| Normal-vs-Extreme_Obese |
7.952400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.189600E-01 |
| Normal_Weight-vs-Obese |
9.491200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.524600E-01 |
| Extreme_Weight-vs-Obese |
4.355400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.957400E-01 |
| Obese-vs-Extreme_Obese |
6.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.188200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.819200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.721400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.822000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.908200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.121800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.367400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.447600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.828800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.927800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.183600E-01 |
| Normal-VS-Type2 PRCC |
5.044400E-01 |
| Normal-VS-KIRP CIMP |
7.837600E-01 |
| Normal-VS-Unclassified PRCC |
7.434200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.916800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.287800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.807600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.050200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.227000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.184800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.898400E-01 |
| Normal-vs-N1 |
4.942400E-01 |
| Normal-vs-N2 |
2.823200E-01 |
| N0-vs-N1 |
1.088030E-01 |
| N0-vs-N2 |
5.669600E-01 |
| N1-vs-N2 |
2.597200E-01 |
|
|
